Report Code: A13940 | Pages: NA | Mar 2023 | 1208 Views | ||
Author(s) : NA | Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Enoxaparin Sodium Market
Request Now !Enoxaparin sodium is an anticoagulant heparin with a low molecular weight drug (blood thinner). It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as to treat and prevent blood clots during pregnancy and after certain types of surgery. Pulmonary embolism occurs when blood clots move through the lungs and get stuck in the blood vessels of lungs. This medication is prescribed for a period of time after knee or hip replacement surgery, as well as in some cases of abdominal surgery and also in the event of a major illness. Moreover, enoxaparin sodium is used in those with acute coronary syndrome (ACS) and heart attack. It is injected into a vein or just beneath the skin. Bleeding, fever, and leg swelling are all common adverse effects. Bleeding might be dangerous, especially if an individual is having a spinal tap.
COVID-19 Impact Analysis
Top Impacting Factors
Increasing prevalence of heart diseases and rising cases of deep vein thrombosis & pulmonary embolism related health problems propel the market growth of enoxaparin sodium market.
 Rising number of surgeries and increasing need for preventing any complications boost the market growth.
Increase in number of Food and Drug Administration approval drugs and surge in the geriatric population are some factors, which boost the market growth.
Rise in awareness for the treatment of several cardiovascular disease fuels the market growth.
In addition, increase in healthcare expenditure, rise in research & development activities conducted by many pharmaceutical companies, launches of novel developed drug in market are some factors which contribute toward the enoxaparin sodium market growth.
However, side effects associated with enoxaparin sodium and availability of alternative drugs are expected to hamper the enoxaparin sodium market growth.
Market Trends
New Product Launches to Flourish the Market
Key Benefits of the Report
Questions Answered in the Enoxaparin Sodium Market Report
Enoxaparin sodium Market Report Highlights
Aspects | Details |
---|---|
By Drug Type |
|
By Application |
|
By Region |
|
Key Market Players | Sanodz, Winthrop U.S., Sanofi, Themis Medicare Limited, Actavis Pharma Company, Shenzhen Techdow Pharmaceutical, NorthStar Rx, Amphastar Pharmaceuticals Inc., Jianyou, Cardinal Health, Teva Parenteral Medicines. |
Loading Table Of Content...
Start reading.
This Report and over 19,603+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers